Placement of multiple negative charges in the linker region of PSMA tracers significantly reduced the non-specific background binding without significant reduction of binding affinity. This increased tumor/background contrast in positron emission tomography promises to provide more sensitive tumor detection while decreasing the overall radiation exposure to patients.
In order to develop a PET radiopharmaceutical to image malignant melanoma, we synthesized N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA). In vitro studies show a high uptake of [18F]-DAFBA by the B16F1 melanoma cells. No significant binding was seen for DAFBA to the sigma-1 and sigma-2 receptors in vitro. The in vivo biodistribution studies performed in normal ICR mice showed a low uptake in the normal tissues followed by further elimination of radioactivity from these tissues with time. The biodistribution studies performed in C57 mice bearing melanoma tumor xenograft showed a rapid uptake of radioactivity in the tumor that reached a plateau within 30 min post injection. The F-18 uptake in the tumor was 7.00±2.76, 6.57±1.66, and 5.80±0.98 %ID/g at 60, 120, and 180 min, respectively. A steady uptake of radioactivity in the tumor and low uptake in normal tissues resulted in high tumor to normal tissue ratios. For example, at 180 min post-injection, the tumor to tissue ratios were 14.90±6.47, 21.90±4.68, 32.91±6.11, 36.73±5.61, and 6.33±1.9, for the spleen, lungs, muscle, blood, and liver, respectively. The radioactivity rapidly cleared from the blood pool and it decrease from 0.58±0.18 %ID/g at 60 min to 0.13±0.03 %ID/g at 180 min. The F-18 uptake in the bones at 60, 120, and 180 min was 0.91±0.27, 0.57±0.32, and 0.17±0.05 %ID/g, respectively. This low uptake in the bones reflects its in vivo resistance towards de-fluorination. A low residual activity in normal tissues and a high tumor uptake signifies a superior imaging potential of this compound. Owing to these positive traits, [18F]-DAFBA could help delineate tumor and its metastases when used for imaging application. Further in vivo studies are underway to assess potential of [18F]-DAFBA as a promising PET imaging probe.
An automated radiosynthesis of carbon‐11 positron emission tomography radiotracer [11C]UCB‐J for imaging the synaptic density biomarker synaptic vesicle glycoprotein SV2A was established using Synthra RNPlus synthesizer. Commercially available trifluoroborate UCB‐J analogue was used as a radiolabelling precursor, and the desired radiolabelled product was isolated in 11 ± 2% (n = 7) nondecay corrected radiochemical yield and formulated as a 10% EtOH solution in saline with molar activities of 20 to 100 GBq/μmol. The method was based upon the palladium(0)‐mediated Suzuki cross‐coupling reaction and [11C]CH3I as a radiolabelling synthon. The isolated product was cGMP compliant as demonstrated by the results of quality control analysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.